565 related articles for article (PubMed ID: 15068900)
21. Detection of residual aneuploid leukemic cells by "continuous gating".
Kleine HD; Zech I; Nowak R; Oelschlägel U; Kundt G; Freund M
Cytometry; 1999 May; 36(1):71-6. PubMed ID: 10331629
[TBL] [Abstract][Full Text] [Related]
22. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation.
Kiel K; Cremer FW; Rottenburger C; Kallmeyer C; Ehrbrecht E; Atzberger A; Hegenbart U; Goldschmidt H; Moos M
Bone Marrow Transplant; 1999 May; 23(10):1019-27. PubMed ID: 10373068
[TBL] [Abstract][Full Text] [Related]
23. DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies.
Montecucco C; Riccardi A; Mazzini G; Danova M; Ucci G; Giordano PA
Basic Appl Histochem; 1985; 29(3):275-82. PubMed ID: 3877500
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
Mateo G; Corral M; Almeida J; López-Berges C; Nieto mJ; García-Marcos A; Vázquez L; del Cañizo C; Orfao A; San Miguel JF
Haematologica; 2003 Sep; 88(9):1013-21. PubMed ID: 12969809
[TBL] [Abstract][Full Text] [Related]
26. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG; von't Veer MB; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
Pilarski LM; Jensen GS
Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotyping of B lymphocytes by multiparametric flow cytometry in bone marrow aspirates and peripheral blood of healthy adults.
Höffkes H; Schmidtke G; Schmücker U; Uppenkamp M; Brittinger G
Eur J Med Res; 1995 Oct; 1(1):2-8. PubMed ID: 9392686
[TBL] [Abstract][Full Text] [Related]
30. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
Kara IO; Duman BB; Afsar CU
J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
[TBL] [Abstract][Full Text] [Related]
31. Markers of multiple hematopoietic-cell lineages in multiple myeloma.
Epstein J; Xiao HQ; He XY
N Engl J Med; 1990 Mar; 322(10):664-8. PubMed ID: 2137556
[TBL] [Abstract][Full Text] [Related]
32. No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myeloma.
Duperray C; Bataille R; Boiron JM; Haagen IA; Cantaloube JF; Zhang XG; Boucheix C; Klein B
Cancer Res; 1991 Jun; 51(12):3224-8. PubMed ID: 1904006
[TBL] [Abstract][Full Text] [Related]
33. A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
Orfäo A; García-Sanz R; López-Berges MC; Belén Vidriales M; González M; Caballero MD; San Miguel JF
Cytometry; 1994 Dec; 17(4):332-9. PubMed ID: 7533074
[TBL] [Abstract][Full Text] [Related]
34. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
Rasmussen T; Lodahl M; Hancke S; Johnsen HE
Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
[TBL] [Abstract][Full Text] [Related]
35. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
[TBL] [Abstract][Full Text] [Related]
36. Peanut agglutinin in combination with CD19 monoclonal antibody has potential as a purging agent in myeloma.
Rhodes EG; Baker P; Rhodes JM; Davies JM; Cawley JC
Exp Hematol; 1991 Sep; 19(8):833-7. PubMed ID: 1714405
[TBL] [Abstract][Full Text] [Related]
37. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
Koníková E; Kusenda J; Babusíková O; Glasová M
Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
[TBL] [Abstract][Full Text] [Related]
38. The clonal hierachy in multiple myeloma.
Rasmussen T; Jensen L; Johnsen HE
Acta Oncol; 2000; 39(7):765-70. PubMed ID: 11145430
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 receptor expression and saturation on the bone marrow cells of patients with multiple myeloma.
Brown RD; Gorenc B; Gibson J; Joshua D
Leukemia; 1993 Feb; 7(2):221-5. PubMed ID: 8426476
[TBL] [Abstract][Full Text] [Related]
40. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]